What strategies have been effective in optimising COVID-19 vaccine uptake in Australia and internationally?

Australia COVID-19 / prevention & control COVID-19 Vaccines / therapeutic use Humans Vaccination Vaccines

Journal

Australian journal of general practice
ISSN: 2208-7958
Titre abrégé: Aust J Gen Pract
Pays: Australia
ID NLM: 101718099

Informations de publication

Date de publication:
09 2022
Historique:
entrez: 1 9 2022
pubmed: 2 9 2022
medline: 9 9 2022
Statut: ppublish

Résumé

A key public health measure protecting the population from COVID-19 is vaccination. Unvaccinated people have higher COVID-19 case rates and death rates than those who are fully or partially vaccinated. It has, and continues to be, critical to optimise COVID-19 vaccination uptake in the community. The aim of this study was to identify population groups who were less likely to be fully vaccinated against COVID-19 and strategies that were successful in increasing uptake in these often hard-to-reach groups. Strategies that have successfully increased COVID-19 vaccine uptake may also be effective in enhancing uptake across a range of vaccine-preventable diseases. These strategies include collaboration and building trust with local communities, targeted communication and education, optimising access to vaccines and the use of targeted incentives. Primary care providers are often central to these strategies and are well placed to take the time that people need to shift from uncertain to becoming vaccinated.

Sections du résumé

BACKGROUND
A key public health measure protecting the population from COVID-19 is vaccination. Unvaccinated people have higher COVID-19 case rates and death rates than those who are fully or partially vaccinated. It has, and continues to be, critical to optimise COVID-19 vaccination uptake in the community.
OBJECTIVE
The aim of this study was to identify population groups who were less likely to be fully vaccinated against COVID-19 and strategies that were successful in increasing uptake in these often hard-to-reach groups.
DISCUSSION
Strategies that have successfully increased COVID-19 vaccine uptake may also be effective in enhancing uptake across a range of vaccine-preventable diseases. These strategies include collaboration and building trust with local communities, targeted communication and education, optimising access to vaccines and the use of targeted incentives. Primary care providers are often central to these strategies and are well placed to take the time that people need to shift from uncertain to becoming vaccinated.

Identifiants

DOI: 10.31128/AJGP-05-22-6427 PMID: 36045631
pubmed: 36045631
doi: 10.31128/AJGP-05-22-6427
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

725-730

Auteurs

Jane Desborough (J)

RN, RM, MPH, PhD, Action Research Fellow, COVID-19 Primary Care Response Group (seconded), Primary Care Division, Australian Government Department of Health, Canberra, ACT; Senior Research Fellow, Research School of Population Health, Australian National University, Canberra, ACT.

Michael Wright (M)

MBBS, MPH, PhD, FRACGP, Resarch Fellow, Centre for Health Economics Research and Evaluation, University Technology Sydney, Broadway, NSW.

Anne Parkinson (A)

BA, PhD, AFHEA, Action Research Fellow, COVID-19 Primary Care Response Group (seconded), Primary Care Division, Australian Government Department of Health, Canberra, ACT; Postdoctoral Fellow, Research School of Population Health, Australian National University, Canberra, ACT.

Sally Hall Dykgraaf (S)

RN, Grad Cert ClinMan, PhD, Action Research Fellow, COVID-19 Primary Care Response Group (seconded), Primary Care Division, Australian Government Department of Health, Canberra, ACT; Research Manager, Rural Clinical School, Australian National University, Canberra, ACT.

Lauren Ball (L)

BAppSc, GCertHEd, GDipHEconHPol, MNutDiet, PhD, Principal Research Fellow, Menzies Health Institute Queensland, Griffith University, Gold Coast, Qld.

Garang M Dut (GM)

MD, MPH, MBA, Action Research Fellow, COVID-19 Primary Care Response Group (seconded), Primary Care Division, Australian Government Department of Health, Canberra, ACT; Fellow in Health Systems, College of Health @ Medicine, Australian National University, Canberra, ACT.

Elizabeth Sturgiss (E)

FRACGP, PhD, BMed, MPH, MForensMed, FHEA, Action Research Fellow, COVID-19 Primary Care Response Group (seconded), Primary Care Division, Australian Government Department of Health, Canberra, ACT; Senior Research Fellow, School of Primary and Allied Health Care, Monash University, Frankston, Vic.

Lucas de Toca (L)

MBBS, First Assistant Secretary, Implementation and Primary Care Response, Primary Care Division, Australian Government Department of Health, Canberra, ACT.

Michael Kidd (M)

AM MBBS, MD, FAHMS, Deputy Chief Medical Officer, Primary Care Division, Australian Government Department of Health, Canberra, ACT; Principal Medical Advisor, Primary Care Division, Australian Government Department of Health, Canberra, ACT; Professor of Primary Care Reform, Australian National University, Canberra, ACT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › What strategies have been effective in...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › What strategies have been effective in...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre la COVID-19 › What strategies have been effective in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › What strategies have been effective in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › What strategies have been effective in...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › What strategies have been effective in...